Loading people...
Rebecca Allan is a PhD candidate in Chemistry at the University of Toronto Mississauga and a researcher in the Gunning Lab, based in Mississauga, Ontario, Canada. She originally conducted research abroad at the Canadian institution during her undergraduate studies before officially entering the direct-entry doctoral program in September 2019. Prior to this transition, Allan earned a Master of Chemistry degree from Cardiff University in the United Kingdom. Her academic research specializes in medicinal chemistry and drug discovery, specifically focusing on the design of small molecules to target proteins associated with rare human diseases. Allan has authored verified publications in her scientific field and received the 2022-2023 PRiME Fellowship to support her ongoing laboratory investigations. Her background combines international academic training with a current focus on developing novel chemical compounds for specialized therapeutic medical applications.
Rebecca Allan is Investor at BoxOne Ventures, based in Toronto, Canada.